MiMedx Group Inc (MDXG)
7.145
-0.22
(-3.05%)
USD |
NASDAQ |
May 06, 14:33
MiMedx Group Cash from Investing (Quarterly): -6.024M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.024M |
| December 31, 2023 | -0.481M |
| September 30, 2023 | -0.649M |
| June 30, 2023 | -0.348M |
| March 31, 2023 | -0.677M |
| December 31, 2022 | -1.709M |
| September 30, 2022 | -0.374M |
| June 30, 2022 | -0.429M |
| March 31, 2022 | -0.148M |
| December 31, 2021 | -0.314M |
| September 30, 2021 | -0.58M |
| June 30, 2021 | -0.422M |
| March 31, 2021 | -2.079M |
| December 31, 2020 | -2.273M |
| September 30, 2020 | -0.71M |
| June 30, 2020 | -0.486M |
| March 31, 2020 | -1.086M |
| December 31, 2019 | -0.793M |
| September 30, 2019 | 2.06M |
| June 30, 2019 | -0.33M |
| March 31, 2019 | -0.433M |
| December 31, 2018 | -1.186M |
| September 30, 2018 | -2.453M |
| June 30, 2018 | -2.474M |
| March 31, 2018 | -3.107M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.255M |
| September 30, 2017 | -1.394M |
| June 30, 2017 | -1.779M |
| March 31, 2017 | -0.969M |
| December 31, 2016 | -1.231M |
| September 30, 2016 | -1.734M |
| June 30, 2016 | 0.573M |
| March 31, 2016 | -9.286M |
| December 31, 2015 | 1.592M |
| September 30, 2015 | -1.105M |
| June 30, 2015 | -0.117M |
| March 31, 2015 | -1.048M |
| December 31, 2014 | -9.845M |
| September 30, 2014 | -0.873M |
| June 30, 2014 | -0.80M |
| March 31, 2014 | -0.634M |
| December 31, 2013 | -0.491M |
| September 30, 2013 | -1.139M |
| June 30, 2013 | -1.322M |
| March 31, 2013 | -0.0735M |
| December 31, 2012 | -0.2351M |
| September 30, 2012 | -0.1634M |
| June 30, 2012 | -0.1917M |
| March 31, 2012 | -0.0468M |
| December 31, 2011 | 0.1818M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-6.024M
Minimum
Mar 2024
2.06M
Maximum
Sep 2019
-0.8926M
Average
-0.533M
Median
Cash from Investing (Quarterly) Benchmarks
| TELA Bio Inc | -0.193M |
| Amylyx Pharmaceuticals Inc | 20.92M |
| CEL-SCI Corp | -0.0649M |
| AIM ImmunoTech Inc | -0.214M |
| IGC Pharma Inc | -0.061M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.978M |
| Cash from Financing (Quarterly) | -33.47M |
| Free Cash Flow | 29.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | 28.48M |
| Free Cash Flow to Firm (Quarterly) | 1.176M |
| Free Cash Flow Yield | 3.09% |